ישראל - עברית - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

ישראל - עברית - Ministry of Health

stern healthcare ltd, israel - ibalizumab - תרכיז להכנת תמיסה לאינפוזיה - ibalizumab 200 mg/vial - ibalizumab

ישראל - עברית - Ministry of Health

sanofi israel ltd - dupilumab - תמיסה להזרקה - dupilumab 150 mg/ml - dupilumab

ישראל - עברית - Ministry of Health

sanofi israel ltd - dupilumab - תמיסה להזרקה - dupilumab 175 mg/ml - dupilumab

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - טבליות מצופות פילם - lenacapavir as sodium 300 mg - lenacapavir

ישראל - עברית - Ministry of Health

gilead sciences israel ltd - lenacapavir as sodium - תמיסה להזרקה - lenacapavir as sodium 309 mg/ml - lenacapavir

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - mepolizumab - אבקה להכנת תמיסה לזריקה - mepolizumab 100 mg - mepolizumab

ישראל - עברית - Ministry of Health

teva israel ltd - reslizumab - תרכיז להכנת תמיסה לאינפוזיה - reslizumab 10 mg / 1 ml - reslizumab

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - benralizumab - תמיסה להזרקה - benralizumab 30 mg / 1 ml - benralizumab

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - mepolizumab - תמיסה להזרקה - mepolizumab 100 mg / 1 ml - mepolizumab